NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
12/14/2025
Back to search
Official data from USPTO
VANGUARD CLINICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
12/15/2025
Trademark type
Combined
Nice classes
35, 42, 45
Filing date
11/09/2018
Registration date
07/02/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/14/2025
Last transaction
12/15/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
02/01/2017
First use in commerce
02/01/2017
Drawing code
3
Owner type
03
Owner location
San Diego, CA
Examiner
HOLTZ, ALLISON
Current location
Historical data usage
Mark description
The mark consists of The word "Vanguard" in the color purple with a teal and gray pill capsule incorporated into the letter "U", the word "Clinical" in gray.
Holders and representatives
Holders
Vanguard Clinical Inc
Representatives
Vanguard Clinical Inc
Technical classification
Nice Classes
Class 35Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval
Class 42
Conducting clinical trials for others
Class 45
Providing independent review of clinical trials involving human subjectsreviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research
Publications
History of USPTO decisions and trademark events.
22 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
12/14/2025
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
12/11/2025
PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
08/02/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/29/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/28/2025
ES8R
TEAS SECTION 8 RECEIVED
04/16/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
07/02/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/16/2019
PUBO
PUBLISHED FOR OPPOSITION
04/16/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/27/2019
ALIE
ASSIGNED TO LIE
03/08/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/14/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
02/14/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/14/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
02/14/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/14/2019
DOCK
ASSIGNED TO EXAMINER
02/14/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/28/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/27/2018
NWAP
NEW APPLICATION ENTERED
11/13/2018
Continuous trademark protection
Get notified about every new filing that threatens VANGUARD CLINICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.